ClinicalTrials.gov
public full text
Public Domain
Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain
The study will be a prospective randomized double-blind placebo-controlled trial of mirabegron for medical expulsive therapy (MET) in patients with a CT (Computed Tomography) scan-proven ureteral stone between 4 to 10 mm undergoing expectant management.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparing Patients After ESWL Treated With Ureteral Stents Versus Expulsion Therapy With Tamsulosin#982099
- MIRABEGRON AND UAS OUTCOMES DURING RIRS#1197656
- ESWL vs Flexible Uretroscopy in Management of Upper Ureteric Stones a Prospective Randomized Study#874979
- Evaluation of Tamsulosin in the Treatment of Ureteral Stones#1173653
- Silodosin Versus Tamsulosin for Treatment of Ureteral Stones#969287
Record · ID 1439993
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive